PATH-21. CLINICAL UTILITY OF DNA METHYLATION PROFILING FOR DIAGNOSIS OF CHALLENGING CENTRAL NERVOUS SYSTEM TUMORS: THE TORONTO EXPERIENCE

The update on the WHO classification of central nervous system (CNS) tumors incorporated molecular signatures for a more accurate diagnosis. Recently, DKFZ has demonstrated the utility of DNA methylation profiling(MP) for molecular classification of CNS tumors. We performed a prospective clinical st...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Neuro Oncol
Autores principales: Karimi, Shirin, Zuccato, Jeffrey, Mamatjan, Yasin, Mansouri, Sheila, Suppiah, Suganth, Nassiri, Farshad, Diamandis, Phedias, Munoz, David, Aldape, Kenneth, Zadeh, Gelareh
Formato: Artigo
Lenguaje:Inglês
Publicado: Oxford University Press 2019
Materias:
Molecular Pathology and Classification - Adult and Pediatric
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC6847817/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noz175.617
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares